4
|
Eslami P, Parmar C, Foldyna B, Scholtz JE, Ivanov A, Zeleznik R, Lu MT, Ferencik M, Vasan RS, Baltrusaitis K, Massaro JM, D’Agostino RB, Mayrhofer T, O’Donnell CJ, Aerts HJWL, Hoffmann U. Radiomics of Coronary Artery Calcium in the Framingham Heart Study. Radiol Cardiothorac Imaging 2020; 2:e190119. [PMID: 32715301 PMCID: PMC7051158 DOI: 10.1148/ryct.2020190119] [Citation(s) in RCA: 21] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2019] [Revised: 10/14/2019] [Accepted: 10/21/2019] [Indexed: 12/19/2022]
Abstract
PURPOSE To extract radiomic features from coronary artery calcium (CAC) on CT images and to determine whether this approach could improve the ability to identify individuals at risk for a composite endpoint of clinical events. MATERIALS AND METHODS Participants from the Offspring and Third Generation cohorts of the community-based Framingham Heart Study underwent noncontrast cardiac CT (2002-2005) and were followed for more than a median of 9.1 years for composite major events. A total of 624 participants with CAC Agatston score (AS) of greater than 0 and good or excellent CT image quality were included for manual CAC segmentation and extraction of a predefined set of radiomic features reflecting intensity, shape, and texture. In a discovery cohort (n = 318), machine learning was used to select the 20 most informative and nonredundant CAC radiomic features, classify features predicting events, and define a radiomic-based score (RS). Performance of the RS was tested independently for the prediction of events in a validation cohort (n = 306). RESULTS The RS had a median value of 0.08 (interquartile range, 0.007-0.71) and a weak and modest correlation with Framingham risk score (FRS) (r = 0.2) and AS (r = 0.39), respectively. The continuous RS unadjusted, adjusted for age and sex, FRS, AS, and FRS plus AS were significantly associated with events (hazard ratio [HR] = 2.2, P < .001; HR = 1.8, P = .002; HR = 2.0, P < .001; HR = 1.7, P = .02; and HR = 1.8, P = .01, respectively). In participants with AS of less than 300, RS association with events remained significant when unadjusted and adjusted for age and sex, FRS, AS, and FRS plus AS (HR = 2.4, 2.8, 2.8, 2.3, and 2.6; P < .001, respectively). In the same subgroup of participants, adding the RS to AS resulted in a significant improvement in the discriminatory ability for events as compared with the AS (area under the receiver operating curve: 0.80 vs 0.68, respectively; P = .03). CONCLUSION A radiomic-based score, including the complex properties of CAC, may constitute an imaging biomarker to be further developed to identify individuals at risk for major adverse cardiovascular events in a community-based cohort. Supplemental material is available for this article. © RSNA, 2020.
Collapse
Affiliation(s)
- Parastou Eslami
- From the Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge St, Suite 400, Boston, MA 02114 (P.E., B.F., J.E.S., A.I., M.T.L., M.F., T.M., U.H.); Department of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (C.P., R.Z., H.J.W.L.A.); Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Ore (M.F.); National Heart, Lung, and Blood Institute’s and Boston University’s Framingham Heart Study, Framingham, Mass (R.S.V., C.J.O.); Department of Mathematics, Boston University, Boston, Mass (K.B., J.M.M., R.B.D.); Institute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany (J.E.S.); and School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany (T.M.)
| | - Chintan Parmar
- From the Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge St, Suite 400, Boston, MA 02114 (P.E., B.F., J.E.S., A.I., M.T.L., M.F., T.M., U.H.); Department of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (C.P., R.Z., H.J.W.L.A.); Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Ore (M.F.); National Heart, Lung, and Blood Institute’s and Boston University’s Framingham Heart Study, Framingham, Mass (R.S.V., C.J.O.); Department of Mathematics, Boston University, Boston, Mass (K.B., J.M.M., R.B.D.); Institute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany (J.E.S.); and School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany (T.M.)
| | - Borek Foldyna
- From the Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge St, Suite 400, Boston, MA 02114 (P.E., B.F., J.E.S., A.I., M.T.L., M.F., T.M., U.H.); Department of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (C.P., R.Z., H.J.W.L.A.); Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Ore (M.F.); National Heart, Lung, and Blood Institute’s and Boston University’s Framingham Heart Study, Framingham, Mass (R.S.V., C.J.O.); Department of Mathematics, Boston University, Boston, Mass (K.B., J.M.M., R.B.D.); Institute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany (J.E.S.); and School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany (T.M.)
| | - Jan-Erik Scholtz
- From the Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge St, Suite 400, Boston, MA 02114 (P.E., B.F., J.E.S., A.I., M.T.L., M.F., T.M., U.H.); Department of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (C.P., R.Z., H.J.W.L.A.); Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Ore (M.F.); National Heart, Lung, and Blood Institute’s and Boston University’s Framingham Heart Study, Framingham, Mass (R.S.V., C.J.O.); Department of Mathematics, Boston University, Boston, Mass (K.B., J.M.M., R.B.D.); Institute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany (J.E.S.); and School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany (T.M.)
| | - Alexander Ivanov
- From the Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge St, Suite 400, Boston, MA 02114 (P.E., B.F., J.E.S., A.I., M.T.L., M.F., T.M., U.H.); Department of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (C.P., R.Z., H.J.W.L.A.); Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Ore (M.F.); National Heart, Lung, and Blood Institute’s and Boston University’s Framingham Heart Study, Framingham, Mass (R.S.V., C.J.O.); Department of Mathematics, Boston University, Boston, Mass (K.B., J.M.M., R.B.D.); Institute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany (J.E.S.); and School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany (T.M.)
| | - Roman Zeleznik
- From the Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge St, Suite 400, Boston, MA 02114 (P.E., B.F., J.E.S., A.I., M.T.L., M.F., T.M., U.H.); Department of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (C.P., R.Z., H.J.W.L.A.); Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Ore (M.F.); National Heart, Lung, and Blood Institute’s and Boston University’s Framingham Heart Study, Framingham, Mass (R.S.V., C.J.O.); Department of Mathematics, Boston University, Boston, Mass (K.B., J.M.M., R.B.D.); Institute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany (J.E.S.); and School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany (T.M.)
| | - Michael T. Lu
- From the Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge St, Suite 400, Boston, MA 02114 (P.E., B.F., J.E.S., A.I., M.T.L., M.F., T.M., U.H.); Department of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (C.P., R.Z., H.J.W.L.A.); Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Ore (M.F.); National Heart, Lung, and Blood Institute’s and Boston University’s Framingham Heart Study, Framingham, Mass (R.S.V., C.J.O.); Department of Mathematics, Boston University, Boston, Mass (K.B., J.M.M., R.B.D.); Institute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany (J.E.S.); and School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany (T.M.)
| | - Maros Ferencik
- From the Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge St, Suite 400, Boston, MA 02114 (P.E., B.F., J.E.S., A.I., M.T.L., M.F., T.M., U.H.); Department of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (C.P., R.Z., H.J.W.L.A.); Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Ore (M.F.); National Heart, Lung, and Blood Institute’s and Boston University’s Framingham Heart Study, Framingham, Mass (R.S.V., C.J.O.); Department of Mathematics, Boston University, Boston, Mass (K.B., J.M.M., R.B.D.); Institute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany (J.E.S.); and School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany (T.M.)
| | - Ramachandran S. Vasan
- From the Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge St, Suite 400, Boston, MA 02114 (P.E., B.F., J.E.S., A.I., M.T.L., M.F., T.M., U.H.); Department of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (C.P., R.Z., H.J.W.L.A.); Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Ore (M.F.); National Heart, Lung, and Blood Institute’s and Boston University’s Framingham Heart Study, Framingham, Mass (R.S.V., C.J.O.); Department of Mathematics, Boston University, Boston, Mass (K.B., J.M.M., R.B.D.); Institute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany (J.E.S.); and School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany (T.M.)
| | - Kristin Baltrusaitis
- From the Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge St, Suite 400, Boston, MA 02114 (P.E., B.F., J.E.S., A.I., M.T.L., M.F., T.M., U.H.); Department of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (C.P., R.Z., H.J.W.L.A.); Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Ore (M.F.); National Heart, Lung, and Blood Institute’s and Boston University’s Framingham Heart Study, Framingham, Mass (R.S.V., C.J.O.); Department of Mathematics, Boston University, Boston, Mass (K.B., J.M.M., R.B.D.); Institute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany (J.E.S.); and School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany (T.M.)
| | - Joseph M. Massaro
- From the Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge St, Suite 400, Boston, MA 02114 (P.E., B.F., J.E.S., A.I., M.T.L., M.F., T.M., U.H.); Department of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (C.P., R.Z., H.J.W.L.A.); Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Ore (M.F.); National Heart, Lung, and Blood Institute’s and Boston University’s Framingham Heart Study, Framingham, Mass (R.S.V., C.J.O.); Department of Mathematics, Boston University, Boston, Mass (K.B., J.M.M., R.B.D.); Institute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany (J.E.S.); and School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany (T.M.)
| | - Ralph B. D’Agostino
- From the Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge St, Suite 400, Boston, MA 02114 (P.E., B.F., J.E.S., A.I., M.T.L., M.F., T.M., U.H.); Department of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (C.P., R.Z., H.J.W.L.A.); Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Ore (M.F.); National Heart, Lung, and Blood Institute’s and Boston University’s Framingham Heart Study, Framingham, Mass (R.S.V., C.J.O.); Department of Mathematics, Boston University, Boston, Mass (K.B., J.M.M., R.B.D.); Institute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany (J.E.S.); and School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany (T.M.)
| | - Thomas Mayrhofer
- From the Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge St, Suite 400, Boston, MA 02114 (P.E., B.F., J.E.S., A.I., M.T.L., M.F., T.M., U.H.); Department of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (C.P., R.Z., H.J.W.L.A.); Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Ore (M.F.); National Heart, Lung, and Blood Institute’s and Boston University’s Framingham Heart Study, Framingham, Mass (R.S.V., C.J.O.); Department of Mathematics, Boston University, Boston, Mass (K.B., J.M.M., R.B.D.); Institute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany (J.E.S.); and School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany (T.M.)
| | - Christopher J. O’Donnell
- From the Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge St, Suite 400, Boston, MA 02114 (P.E., B.F., J.E.S., A.I., M.T.L., M.F., T.M., U.H.); Department of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (C.P., R.Z., H.J.W.L.A.); Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Ore (M.F.); National Heart, Lung, and Blood Institute’s and Boston University’s Framingham Heart Study, Framingham, Mass (R.S.V., C.J.O.); Department of Mathematics, Boston University, Boston, Mass (K.B., J.M.M., R.B.D.); Institute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany (J.E.S.); and School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany (T.M.)
| | - Hugo J. W. L. Aerts
- From the Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge St, Suite 400, Boston, MA 02114 (P.E., B.F., J.E.S., A.I., M.T.L., M.F., T.M., U.H.); Department of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (C.P., R.Z., H.J.W.L.A.); Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Ore (M.F.); National Heart, Lung, and Blood Institute’s and Boston University’s Framingham Heart Study, Framingham, Mass (R.S.V., C.J.O.); Department of Mathematics, Boston University, Boston, Mass (K.B., J.M.M., R.B.D.); Institute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany (J.E.S.); and School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany (T.M.)
| | - Udo Hoffmann
- From the Cardiovascular Imaging Research Center, Massachusetts General Hospital, Harvard Medical School, 165 Cambridge St, Suite 400, Boston, MA 02114 (P.E., B.F., J.E.S., A.I., M.T.L., M.F., T.M., U.H.); Department of Radiation Oncology and Radiology, Dana-Farber Cancer Institute, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass (C.P., R.Z., H.J.W.L.A.); Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Ore (M.F.); National Heart, Lung, and Blood Institute’s and Boston University’s Framingham Heart Study, Framingham, Mass (R.S.V., C.J.O.); Department of Mathematics, Boston University, Boston, Mass (K.B., J.M.M., R.B.D.); Institute for Diagnostic and Interventional Radiology, University Hospital Frankfurt, Frankfurt, Germany (J.E.S.); and School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany (T.M.)
| |
Collapse
|